Novavax (NVAX) X Mentions Statistics 2025

19 42.4%

1W 86.7%

Est. daily mentions of Cashtag on X.

Similar companies

Company		X Mentions
	Amgen AMGN	11 31.3%
	Gilead Sciences GILD	24 71.4%
	Catalyst Pharmaceuticals CPRX	1
	Inovio Pharmaceuticals INO	12 20%
	Anavex Life Sciences AVXL	3 50%

Analyzing X Mentions, how is Novavax performing compared to its industry peers?

Novavax underperforms its industry peers when it comes to X Mentions, ranking in the 2nd percentile.

Why should an investor track X mentions?

Investors should track mentions of Novavax on X because sudden increases in activity often reflect shifts in retail interest, sentiment, or breaking news. These signals can precede sharp price movements, offering valuable context for timing trades or identifying emerging opportunities.

Sentiment on X

The sentiment score for Novavax on X is 25 (out of 100). This is considered bearish. Sentiment today is down compared to the 30 moving average.

Top Mentions

Novavax $NVAX will sell and transfer a Maryland facility for $60M in cash, cutting costs by $230M over...

Oct 22 - 4 retweets

Thoughts on Novavax’s stock price today. $NVAX There is a good chance that this is “Spoofing”,...

Oct 20 - 3 retweets

$NVAX BULL FLAG https://t.co/faBwE7v2R3

Oct 22 - 2 retweets

𝗩Ö𝗟𝗟𝗜𝗚 𝗜𝗥𝗥𝗘! Über 65% des Floats von $BYND sind short. Das ist gigantisch!...

Oct 22 - 2 retweets

$NVAX “Himanshu Shah, founder of the fund, told Reuters that Novavax could get a valuation of "at least...

Oct 20 - 2 retweets

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.